Page last updated: 2024-08-24

zileuton and via 2291

zileuton has been researched along with via 2291 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basha, A; Bhatia, P; Bouska, JB; Brooks, CD; Craig, RA; Kolasa, T; Lanni, C; Martin, JG; Ratajczyk, JD; Stewart, AO1
Brooks, CD; Summers, JB1
Bell, RL; Bhatia, PA; Bouska, JB; Brooks, CD; Carter, GW; Craig, RA; DeNinno, SL; Holms, JH; Kerdesky, FA; Kolasa, T; Lanni, C; Maki, RG; Martin, JG; Martin, MB; Mazdiyasni, H; Moore, JL; Ratajczyk, JD; Rodriques, KE; Stewart, AO; Summers, JB; Young, PR1
Hopper, AT; Witiak, DT; Ziemniak, J1
Bayless, L; Eckman, JB; Ellis, JL; Grewal, G; Lewis, TA; Libertine, L; Marie Nicolas, J; Scannell, RT; Wels, BF; Wenberg, K; Wypij, DM1
Bell, RL; Harris, RR; Komater, VA; Marett, RA; Wilcox, DM1

Reviews

1 review(s) available for zileuton and via 2291

ArticleYear
Modulators of leukotriene biosynthesis and receptor activation.
    Journal of medicinal chemistry, 1996, Jul-05, Volume: 39, Issue:14

    Topics: 5-Lipoxygenase-Activating Proteins; Animals; Carrier Proteins; Forecasting; Humans; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Molecular Structure; Receptors, Leukotriene

1996

Other Studies

5 other study(ies) available for zileuton and via 2291

ArticleYear
(R)-(+)-N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl- 2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitor.
    Journal of medicinal chemistry, 1995, Nov-24, Volume: 38, Issue:24

    Topics: Animals; Humans; Hydroxyurea; Lipoxygenase Inhibitors; Macaca fascicularis; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship

1995
Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors.
    Journal of medicinal chemistry, 1997, Jun-20, Volume: 40, Issue:13

    Topics: Animals; Cells, Cultured; Drug Design; Enzyme Inhibitors; Furans; Glucuronates; Humans; Hydroxyurea; Lipoxygenase Inhibitors; Macaca fascicularis; Models, Chemical; Rats; Structure-Activity Relationship; Templates, Genetic; Thiophenes

1997
Design, synthesis, and biological evaluation of conformationally constrained aci-reductone mimics of arachidonic acid.
    Journal of medicinal chemistry, 1998, Feb-12, Volume: 41, Issue:4

    Topics: Animals; Antioxidants; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cell Line, Transformed; Cell Nucleus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Design; Indicators and Reagents; Isoenzymes; Lipopolysaccharides; Lipoxygenase Inhibitors; Macrophages, Peritoneal; Malondialdehyde; Membrane Proteins; Models, Molecular; Molecular Conformation; Molecular Structure; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Rats; Structure-Activity Relationship

1998
5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.
    Bioorganic & medicinal chemistry letters, 2004, May-03, Volume: 14, Issue:9

    Topics: Animals; Caco-2 Cells; Histamine H1 Antagonists; Humans; Lipoxygenase Inhibitors; Microsomes, Liver; Rats

2004
Effect of mast cell deficiency and leukotriene inhibition on the influx of eosinophils induced by eotaxin.
    Journal of leukocyte biology, 1997, Volume: 62, Issue:5

    Topics: Animals; Chemokine CCL11; Chemokines, CC; Cytokines; Eosinophils; Hydroxyurea; Injections, Intraperitoneal; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Mast Cells; Mice; Mice, Inbred BALB C; Peritoneal Cavity

1997